WO2007140717A1 - Ligands diphosphine à motif ruthénocène de symétrie c2 n'ayant qu'une chiralité de surface et fabrication de ceux-ci - Google Patents
Ligands diphosphine à motif ruthénocène de symétrie c2 n'ayant qu'une chiralité de surface et fabrication de ceux-ci Download PDFInfo
- Publication number
- WO2007140717A1 WO2007140717A1 PCT/CN2007/001824 CN2007001824W WO2007140717A1 WO 2007140717 A1 WO2007140717 A1 WO 2007140717A1 CN 2007001824 W CN2007001824 W CN 2007001824W WO 2007140717 A1 WO2007140717 A1 WO 2007140717A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- chiral
- structural formula
- ruthenocene
- group
- ligand
- Prior art date
Links
- 239000003446 ligand Substances 0.000 title claims abstract description 49
- FZHCFNGSGGGXEH-UHFFFAOYSA-N ruthenocene Chemical compound [Ru+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 FZHCFNGSGGGXEH-UHFFFAOYSA-N 0.000 title claims abstract description 17
- VURFVHCLMJOLKN-UHFFFAOYSA-N diphosphane Chemical compound PP VURFVHCLMJOLKN-UHFFFAOYSA-N 0.000 title claims abstract 12
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- -1 alkyloxyl Chemical group 0.000 claims abstract description 63
- 238000006243 chemical reaction Methods 0.000 claims abstract description 34
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims abstract description 20
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 16
- 150000001875 compounds Chemical class 0.000 claims abstract description 13
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 8
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims abstract description 7
- 125000003118 aryl group Chemical group 0.000 claims abstract description 6
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 27
- 239000002904 solvent Substances 0.000 claims description 23
- 238000003786 synthesis reaction Methods 0.000 claims description 15
- 239000002585 base Substances 0.000 claims description 14
- 230000015572 biosynthetic process Effects 0.000 claims description 13
- 239000002253 acid Substances 0.000 claims description 10
- 238000001308 synthesis method Methods 0.000 claims description 7
- 239000002168 alkylating agent Substances 0.000 claims description 6
- 229940100198 alkylating agent Drugs 0.000 claims description 6
- 125000003504 2-oxazolinyl group Chemical group O1C(=NCC1)* 0.000 claims description 5
- 150000004703 alkoxides Chemical class 0.000 claims description 5
- 229910052783 alkali metal Inorganic materials 0.000 claims description 4
- 150000001340 alkali metals Chemical group 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 claims description 3
- 239000012280 lithium aluminium hydride Substances 0.000 claims description 3
- QMVQPDHYQQDAJA-UHFFFAOYSA-N phosphane;ruthenium Chemical compound P.P.[Ru] QMVQPDHYQQDAJA-UHFFFAOYSA-N 0.000 claims description 3
- 230000010933 acylation Effects 0.000 claims description 2
- 238000005917 acylation reaction Methods 0.000 claims description 2
- 230000007062 hydrolysis Effects 0.000 claims description 2
- 238000006460 hydrolysis reaction Methods 0.000 claims description 2
- 238000006555 catalytic reaction Methods 0.000 abstract description 6
- 125000000753 cycloalkyl group Chemical group 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 3
- 125000003710 aryl alkyl group Chemical group 0.000 abstract description 2
- 150000002148 esters Chemical group 0.000 abstract description 2
- 235000010290 biphenyl Nutrition 0.000 abstract 2
- 239000004305 biphenyl Substances 0.000 abstract 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 abstract 2
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 230000029936 alkylation Effects 0.000 abstract 1
- 238000005804 alkylation reaction Methods 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 47
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 33
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 27
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 26
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 25
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 17
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 235000019439 ethyl acetate Nutrition 0.000 description 11
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 8
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- 150000008431 aliphatic amides Chemical class 0.000 description 8
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 8
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 8
- 150000004292 cyclic ethers Chemical class 0.000 description 8
- 150000008282 halocarbons Chemical class 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 8
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 8
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 230000003197 catalytic effect Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000012046 mixed solvent Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 5
- 239000012267 brine Substances 0.000 description 5
- 239000003208 petroleum Substances 0.000 description 5
- 230000035484 reaction time Effects 0.000 description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
- BWZVCCNYKMEVEX-UHFFFAOYSA-N 2,4,6-Trimethylpyridine Chemical compound CC1=CC(C)=NC(C)=C1 BWZVCCNYKMEVEX-UHFFFAOYSA-N 0.000 description 4
- HWWYDZCSSYKIAD-UHFFFAOYSA-N 3,5-dimethylpyridine Chemical compound CC1=CN=CC(C)=C1 HWWYDZCSSYKIAD-UHFFFAOYSA-N 0.000 description 4
- ITQTTZVARXURQS-UHFFFAOYSA-N 3-methylpyridine Chemical compound CC1=CC=CN=C1 ITQTTZVARXURQS-UHFFFAOYSA-N 0.000 description 4
- FKNQCJSGGFJEIZ-UHFFFAOYSA-N 4-methylpyridine Chemical compound CC1=CC=NC=C1 FKNQCJSGGFJEIZ-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 4
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 150000005215 alkyl ethers Chemical class 0.000 description 4
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 4
- 150000002009 diols Chemical class 0.000 description 4
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 4
- GDXHBFHOEYVPED-UHFFFAOYSA-N 1-(2-butoxyethoxy)butane Chemical compound CCCCOCCOCCCC GDXHBFHOEYVPED-UHFFFAOYSA-N 0.000 description 3
- RFRXYOZZAPXFFD-UHFFFAOYSA-N 1-phenylmethoxyethoxymethylbenzene Chemical compound C=1C=CC=CC=1COC(C)OCC1=CC=CC=C1 RFRXYOZZAPXFFD-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- JFBZPFYRPYOZCQ-UHFFFAOYSA-N [Li].[Al] Chemical group [Li].[Al] JFBZPFYRPYOZCQ-UHFFFAOYSA-N 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- KTWOOEGAPBSYNW-UHFFFAOYSA-N ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- LZDKZFUFMNSQCJ-UHFFFAOYSA-N 1,2-diethoxyethane Chemical compound CCOCCOCC LZDKZFUFMNSQCJ-UHFFFAOYSA-N 0.000 description 2
- NRGGMCIBEHEAIL-UHFFFAOYSA-N 2-ethylpyridine Chemical compound CCC1=CC=CC=N1 NRGGMCIBEHEAIL-UHFFFAOYSA-N 0.000 description 2
- XWKFPIODWVPXLX-UHFFFAOYSA-N 2-methyl-5-methylpyridine Natural products CC1=CC=C(C)N=C1 XWKFPIODWVPXLX-UHFFFAOYSA-N 0.000 description 2
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 2
- HBNICUCGMMJTCX-UHFFFAOYSA-N 3,4,5,5a,6,7,8,9-octahydropyrido[1,2-c][1,3]diazepine Chemical compound C1=NCCCC2CCCCN21 HBNICUCGMMJTCX-UHFFFAOYSA-N 0.000 description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 description 2
- VJXRKZJMGVSXPX-UHFFFAOYSA-N 4-ethylpyridine Chemical compound CCC1=CC=NC=C1 VJXRKZJMGVSXPX-UHFFFAOYSA-N 0.000 description 2
- UALKADRSKIFXHX-UHFFFAOYSA-N C(C)N(C1=CC=CC=C1)CC.NN Chemical compound C(C)N(C1=CC=CC=C1)CC.NN UALKADRSKIFXHX-UHFFFAOYSA-N 0.000 description 2
- VYZJCDATOOFAHF-UHFFFAOYSA-N C(C)N(C1CCCCC1)CC.NN Chemical compound C(C)N(C1CCCCC1)CC.NN VYZJCDATOOFAHF-UHFFFAOYSA-N 0.000 description 2
- HUQHXDLDYJONSB-UHFFFAOYSA-N CN(C1CCCCC1)C.NN Chemical compound CN(C1CCCCC1)C.NN HUQHXDLDYJONSB-UHFFFAOYSA-N 0.000 description 2
- KSTCCNSXHIGYPJ-UHFFFAOYSA-N CN(CC1=CC=CC=C1)C.NN Chemical compound CN(CC1=CC=CC=C1)C.NN KSTCCNSXHIGYPJ-UHFFFAOYSA-N 0.000 description 2
- BEQLZGUSGGUTSC-UHFFFAOYSA-N CN1CCN(CC1)C.NN Chemical compound CN1CCN(CC1)C.NN BEQLZGUSGGUTSC-UHFFFAOYSA-N 0.000 description 2
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 2
- 229910001863 barium hydroxide Inorganic materials 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 2
- 239000000920 calcium hydroxide Substances 0.000 description 2
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 125000003074 decanoyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 2
- 229960005215 dichloroacetic acid Drugs 0.000 description 2
- 239000012971 dimethylpiperazine Substances 0.000 description 2
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 2
- QEWYKACRFQMRMB-UHFFFAOYSA-N fluoroacetic acid Chemical compound OC(=O)CF QEWYKACRFQMRMB-UHFFFAOYSA-N 0.000 description 2
- 238000007306 functionalization reaction Methods 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- TZIHFWKZFHZASV-UHFFFAOYSA-N methyl formate Chemical compound COC=O TZIHFWKZFHZASV-UHFFFAOYSA-N 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 239000011736 potassium bicarbonate Substances 0.000 description 2
- 235000015497 potassium bicarbonate Nutrition 0.000 description 2
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 235000011181 potassium carbonates Nutrition 0.000 description 2
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 2
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 2
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- SMUQFGGVLNAIOZ-UHFFFAOYSA-N quinaldine Chemical compound C1=CC=CC2=NC(C)=CC=C21 SMUQFGGVLNAIOZ-UHFFFAOYSA-N 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 238000007142 ring opening reaction Methods 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- ZZXUZKXVROWEIF-UHFFFAOYSA-N 1,2-butylene carbonate Chemical compound CCC1COC(=O)O1 ZZXUZKXVROWEIF-UHFFFAOYSA-N 0.000 description 1
- FSSPGSAQUIYDCN-UHFFFAOYSA-N 1,3-Propane sultone Chemical compound O=S1(=O)CCCO1 FSSPGSAQUIYDCN-UHFFFAOYSA-N 0.000 description 1
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 1
- YBNJPDABDYXSCG-UHFFFAOYSA-N 2,2-bis(phenylmethoxy)acetic acid Chemical compound C=1C=CC=CC=1COC(C(=O)O)OCC1=CC=CC=C1 YBNJPDABDYXSCG-UHFFFAOYSA-N 0.000 description 1
- GSWMRKGWNADDJL-UHFFFAOYSA-N 2,2-dimethoxyacetonitrile Chemical compound COC(OC)C#N GSWMRKGWNADDJL-UHFFFAOYSA-N 0.000 description 1
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- PREOEEDHHXCXJX-UHFFFAOYSA-N 3-methyl-1,3-oxazol-2-one Chemical compound CN1C=COC1=O PREOEEDHHXCXJX-UHFFFAOYSA-N 0.000 description 1
- VGTJCGCQPAOVBT-UHFFFAOYSA-N CN(C1=CC=CC=C1)C.NN Chemical compound CN(C1=CC=CC=C1)C.NN VGTJCGCQPAOVBT-UHFFFAOYSA-N 0.000 description 1
- GPWFRBGAWYSPEO-UHFFFAOYSA-N CONC(=NOC)OC Chemical compound CONC(=NOC)OC GPWFRBGAWYSPEO-UHFFFAOYSA-N 0.000 description 1
- OIFBSDVPJOWBCH-UHFFFAOYSA-N Diethyl carbonate Chemical compound CCOC(=O)OCC OIFBSDVPJOWBCH-UHFFFAOYSA-N 0.000 description 1
- BVTJGGGYKAMDBN-UHFFFAOYSA-N Dioxetane Chemical compound C1COO1 BVTJGGGYKAMDBN-UHFFFAOYSA-N 0.000 description 1
- KMTRUDSVKNLOMY-UHFFFAOYSA-N Ethylene carbonate Chemical compound O=C1OCCO1 KMTRUDSVKNLOMY-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 1
- AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methylaniline Chemical compound CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000000746 allylic group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- ZSWFCLXCOIISFI-UHFFFAOYSA-N cyclopentadiene Chemical group C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 238000005888 cyclopropanation reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 1
- IEJIGPNLZYLLBP-UHFFFAOYSA-N dimethyl carbonate Chemical compound COC(=O)OC IEJIGPNLZYLLBP-UHFFFAOYSA-N 0.000 description 1
- ASQQEOXYFGEFKQ-UHFFFAOYSA-N dioxirane Chemical compound C1OO1 ASQQEOXYFGEFKQ-UHFFFAOYSA-N 0.000 description 1
- 150000004862 dioxolanes Chemical class 0.000 description 1
- 229960004242 dronabinol Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- OJCSPXHYDFONPU-UHFFFAOYSA-N etoac etoac Chemical compound CCOC(C)=O.CCOC(C)=O OJCSPXHYDFONPU-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 description 1
- 238000013332 literature search Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 229940017219 methyl propionate Drugs 0.000 description 1
- DMQSHEKGGUOYJS-UHFFFAOYSA-N n,n,n',n'-tetramethylpropane-1,3-diamine Chemical compound CN(C)CCCN(C)C DMQSHEKGGUOYJS-UHFFFAOYSA-N 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000005556 structure-activity relationship Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 125000005023 xylyl group Chemical group 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F17/00—Metallocenes
- C07F17/02—Metallocenes of metals of Groups 8, 9 or 10 of the Periodic Table
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/22—Organic complexes
- B01J31/2282—Unsaturated compounds used as ligands
- B01J31/2295—Cyclic compounds, e.g. cyclopentadienyls
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
- B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
- B01J31/2409—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring with more than one complexing phosphine-P atom
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/02—Compositional aspects of complexes used, e.g. polynuclearity
- B01J2531/0202—Polynuclearity
- B01J2531/0205—Bi- or polynuclear complexes, i.e. comprising two or more metal coordination centres, without metal-metal bonds, e.g. Cp(Lx)Zr-imidazole-Zr(Lx)Cp
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/02—Compositional aspects of complexes used, e.g. polynuclearity
- B01J2531/0261—Complexes comprising ligands with non-tetrahedral chirality
- B01J2531/0263—Planar chiral ligands, e.g. derived from donor-substituted paracyclophanes and metallocenes or from substituted arenes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
- B01J2531/80—Complexes comprising metals of Group VIII as the central metal
- B01J2531/82—Metals of the platinum group
- B01J2531/821—Ruthenium
Definitions
- the invention relates to a chiral ligand in the technical field of chemical industry and a synthesis method thereof, and particularly relates to a symmetric chiral bisphosphine ligand having only a chirality and a synthesis method thereof.
- Asymmetric catalytic organic synthesis is one of the most effective and advantageous methods for obtaining chiral compounds.
- the key to achieving high reactivity and high enantioselectivity lies in the structure of the chiral phosphine ligand. Therefore, the development of chiral phosphine ligands has been a key research area of concern to academics and industry.
- the size of the dihedral angle formed by the coordination of the chiral ligand with the metal in the asymmetric catalytic reaction is often the key factor affecting the asymmetric induction in the catalytic reaction. This small shift in the angle can greatly affect the stereoselectivity of the asymmetric catalytic reaction. It can be speculated that for the ferrocene-based ligand, it is possible to change the distance between the two cyclopentadiene rings by changing the metallocene, thereby changing the dihedral angle (torsion angle) formed when the ligand is coordinated with the metal. , eventually changing the chiral field of the catalytic reaction.
- Object of the present invention is for the deficiencies of the prior art, to provide a c 2 - ruthenocene symmetric bisphosphine ligand having chiral surface only, it can be selected having better catalytic asymmetric effect A chiral ligand for fruit.
- C 2 according to the present invention - ruthenocene symmetric bisphosphine ligand having chiral surface only, which is shown in the structural formula of formula (La) or (lb).
- the surface chirality of the ligand of the present invention is the S, S configuration.
- R 1 in the structural formula is a phenyl group.
- the present invention also provides a method for synthesizing a C 2 -symmetric only chiral bisphosphonium bisphosphine ligand having a chirality, characterized in that
- R and R 1 have the same meanings as described above.
- the synthesis method includes:
- Step (1) After reacting the dioxazoline compound represented by the following structural formula (2) with an acid in a solvent to break the oxazoline ring, the obtained compound is reacted with acetic anhydride to obtain a corresponding ester amide compound.
- R 1 represents the same meaning as described above, and R 2 represents a fluorenyl group; and the step (2A): the ester amide compound and the structural formula as described below - R - OM The alkoxide is reacted, wherein R represents the same meaning as described above, and M represents an alkali metal atom.
- the present invention also provides a method for synthesizing a C 2 -symmetric only chiral bisphosphonium bisphosphine ligand having a chirality, characterized in that
- R and R 1 have the same meanings as described above.
- the synthesis method includes:
- Step (1) After reacting the dioxazoline compound represented by the following structural formula (2) with an acid in a solvent to break the oxazoline ring, the obtained compound is reacted with acetic anhydride to obtain a corresponding ester amide compound.
- R 1 represents the same meaning as described above, and R 2 represents an alkyl group;
- the alkylating agent represented is subjected to a reaction under basic conditions, wherein R represents the same meaning as described above.
- the present invention also provides a C 2 - synthesis of symmetrical bis ruthenium bisphosphine ligand having a chiral planes only, characterized in that, in said step (1), the acid is trifluoroacetic acid.
- the present invention provides a C 2 - synthesis of ruthenocene symmetric bisphosphine ligands have only chiral planes, characterized in that, in said step (1), under conditions in trifluoroacetic acid in the presence of Hydrolysis is carried out, and the obtained hydrolyzed product is reacted with acetic anhydride under basic conditions to carry out acylation. Further, the present invention also provides a C 2 - synthesis of ruthenocene symmetric bisphosphine ligands have only chiral planes, characterized in that, in said step (2B), the strong base is lithium aluminum tetrahydrocannabinol .
- Ligand of the present invention having a chiral planes only and C 2 - symmetric bisphosphine ligand.
- Such ligands can be used in various metal-catalyzed asymmetric reactions, such as asymmetric cyclopropanation, allyl substitution, functionalization or non-functionalization of olefins and hydrogenation of imines, etc. High reactivity and stereoselectivity have good application prospects.
- ligands of the present invention a new class of chiral plane only and C 2 - symmetric bisphosphine ligand ruthenocene based. Further, the law between the structure-activity relationship of the ligand and the asymmetric catalytic effect in this field can be found. As a guide, a novel catalyst with high catalytic activity and high enantioselectivity can be designed and synthesized. detailed description
- C of the present invention is 2 - ruthenocene symmetric bisphosphine ligand having a chiral planes only, the structural formula of formula (La) or (lb).
- R each represents a methyl group or an ethyl group
- R 1 represents a linear or branched alkyl group, a cycloalkyl group, an alkoxy group, an aryl group, or an aralkyl group.
- Specific examples of the linear or branched alkyl group include methyl group, ethyl group, n-propyl group, isobutyl group, t-butyl group, n-hexyl group, isohexyl group, n-heptyl group, n-octyl group and isooctyl group.
- a linear or branched fluorenyl group having 1 to 18 carbon atoms such as n-decyl, n-octadecyl or iso-octadecyl, etc., of these alkyl groups, preferably a linear chain having 1 to 5 carbon atoms or Branched alkyl.
- the cycloalkyl group include a cyclopentyl group, a cyclohexyl group and the like.
- the aryl group include a phenyl group, a tolyl group, a xylyl group, and a naphthyl group.
- the aryl group may, for example, be a benzyl group or a phenethyl group.
- R 1 in the structural formula is a phenyl group.
- step (1) is first carried out according to the following reaction mechanism (1), that is, The bisoxazoline compound represented by the structural formula (2) and the acid are reacted in a solvent. After the oxazoline ring is opened (hereinafter referred to as "the first one-1 reaction"), the obtained compound is reacted with acetic anhydride (hereinafter referred to as "the first 1-2 reaction,”) to obtain the corresponding ester amide compound (structural formula (3). )), after that, perform the following steps (2A) or (2B).
- R represents the same meaning as described above.
- R 2 represents an alkyl group, and the kind of the alkyl group is not particularly limited. For example, a lower alkyl group having 1 to 5 carbon atoms such as a methyl group, an ethyl group or a propyl group is preferable.
- Examples of the acid used in the first one reaction include hydrochloric acid, sulfuric acid, oxalic acid, phosphoric acid, perchloric acid, periodic acid, hydrogen fluoride acid, methanesulfonic acid, p-toluenesulfonic acid, benzenesulfonic acid, and the like.
- the fluoroacetic acid, glacial acetic acid, and the like may be used alone or in combination of two or more. Among them, trifluoroacetic acid is particularly preferable.
- the acid is used in an amount of from 1 to 50 moles, preferably from 15 to 35 moles, per mole of the mole of the oxazoline compound of the formula (2).
- examples of the solvent to be used include water, a lower halogenated hydrocarbon, an aromatic hydrocarbon, a di-lower alkyl ether, a cyclic ether, a lower dialkyloxyethane, and an aliphatic amide. These may be used alone or in combination. Two or more types are used as a mixed solvent.
- examples of the organic solvent include a lower halogenated hydrocarbon such as chloroform, dichloromethane, dichloroacetic acid or carbon tetrachloride, an aromatic hydrocarbon such as benzene or chlorobenzene, or a di-lower alkyl such as diethyl ether or dimethyl ether.
- the solvent used in the first one reaction is preferably a mixed solvent of water and tetrahydrofuran.
- the 1-1 reaction is carried out under the following reaction conditions to carry out a ring opening reaction of the bisoxazoline compound, That is, the reaction temperature is 40 ° C or lower, preferably 20 to 30 ° C, and the reaction time is 5 hours or longer, preferably 10 to 30 hours.
- step (1) after the first one-first reaction, the first one-two reaction is carried out, and the compound obtained in the ring-opening reaction of the above oxazoline compound is reacted with acetic anhydride in a solvent.
- the amount of the acetic anhydride to be added is 2 to 50 moles, preferably 30 to 40 moles, per mole of the oxazoline compound of the above structural formula (2).
- the solvent used in the first one-second reaction include a lower halogenated hydrocarbon, an aromatic hydrocarbon, a di-lower alkyl ether, a cyclic ether, a lower dioxetane, an aliphatic amide, etc., which can be used alone. Two or more types may be used in combination as a mixed solvent.
- lower halogenated hydrocarbons such as chloroform, dichloromethane, dichloroacetic acid, and carbon tetrachloride
- aromatic hydrocarbons such as benzene and chlorobenzene
- di-lower alkyls such as diethyl ether and dimethyl ether.
- the lower dialkoxy ethane such as dibenzyloxyacetate or an aliphatic amide such as dimethylformamide may be used alone or in combination of two or more.
- the reaction efficiency can be improved by carrying out the reaction under basic conditions.
- the base which can be used include inorganic bases such as sodium hydroxide, sodium carbonate, sodium hydrogencarbonate, potassium hydroxide, potassium carbonate, potassium hydrogencarbonate, calcium hydroxide, calcium carbonate, barium hydroxide, and ammonia.
- the reaction conditions of the first one-two reaction are as follows:
- the reaction temperature is 10 to 50 ° C, preferably 10 to 35 ° C, and the reaction time is 5 hours or longer, preferably 10 to 30 hours.
- the step (2A) or (2B) is carried out by using the ester amide compound obtained in the above step (1), whereby the target product, that is, C 2 represented by the structural formula (la) or (lb) can be obtained.
- the target product that is, C 2 represented by the structural formula (la) or (lb)
- Symmetrical halophosphonium bisphosphine ligands having only a chirality.
- R and R 1 have the same meanings as described above.
- R represents the same meaning as R in the above structural formula (la), and specifically, as described above, R represents a methyl group or an ethyl group. Further, M in the formula represents an alkali metal atom such as sodium or potassium.
- the alkoxide is added in an amount of 10 to 100 times by mole, preferably 30 to 50 times by mole, based on the mole of the ester amide compound (formula (3)) obtained in the step (1).
- examples of the solvent that can be used include a lower halogenated hydrocarbon, an aromatic hydrocarbon, a di-lower alkyl ether, a cyclic ether, a lower dioxirane, an aliphatic amide, etc., which may be used alone or in combination. Two or more types are used in combination as a mixed solvent. Specific examples thereof include lower halogenated hydrocarbons such as chloroform, dichloromethane, dichloroethane, and carbon tetrachloride; aromatic hydrocarbons such as benzene and chlorobenzene; and di-lower alkyls such as diethyl ether and dimethyl ether.
- lower halogenated hydrocarbons such as chloroform, dichloromethane, dichloroethane, and carbon tetrachloride
- aromatic hydrocarbons such as benzene and chlorobenzene
- di-lower alkyls such as diethyl ether and dimethyl ether.
- the above-mentioned solvent may be used alone or in combination of two or more kinds thereof, such as a lower dimethoxy acetonitrile such as dibenzyloxyethane or an aliphatic amide such as dimethylformamide.
- the reaction conditions are as follows: The reaction temperature is 10 to 100 ° C, preferably 5 to 30 ° C, and the reaction time is 5 hours or longer, preferably 12 to 24 hours.
- step (2B) the ester amide compound (formula (3)) obtained in the above step (1) is reacted with a strong base, and the resultant product is represented by the following structural formula: R 2 S0 4 (where R represents the same meaning as above.)
- the alkylating agent represented is reacted under basic conditions to obtain a C 2 -symmetric, only chiral chiral bisphosphonium compound as shown in the structural formula (lb). body,
- R and R 1 have the same meanings as described above.
- the ester amide compound (formula (3)) obtained in the above step (1) is allowed to react with a strong base in a solvent.
- the strong base to be used may, for example, be metal sodium, potassium metal, lithium alkylate or lithium aluminum hydride. Among them, lithium aluminum hydride is particularly preferable.
- the amount of the strong base added is from 1 to 20 moles, preferably from 3 to 10 moles, per mole of the number of moles of the ester amide compound (formula (3)) obtained in the step (1).
- the solvent to be used examples include a lower halogenated hydrocarbon, an aromatic hydrocarbon, a di-lower alkyl ether, a cyclic ether, a lower dialkyloxyethane, and an aliphatic amide. These may be used alone or in combination of two. The above is used as a mixed solvent. Specific examples thereof include lower halogenated hydrocarbons such as chloroform, dichloromethane, dichloroethane, and carbon tetrachloride; aromatic hydrocarbons such as benzene and chlorobenzene; and di-lower alkyls such as diethyl ether and dimethyl ether.
- lower halogenated hydrocarbons such as chloroform, dichloromethane, dichloroethane, and carbon tetrachloride
- aromatic hydrocarbons such as benzene and chlorobenzene
- di-lower alkyls such as diethyl ether and dimethyl ether.
- the lower dialkoxy ethane such as dibenzyloxyethane, an aliphatic amide such as dimethylformamide, or the like may be used alone or in combination of two or more.
- the reaction conditions are as follows: The reaction temperature is 10 to 100 ° C, preferably 5 to 30 ° C, and the reaction time is 1 hour or longer, preferably 1 to 8 hours.
- product (2bj) the product obtained above (hereinafter referred to as "product (2bj)") is reacted with an alkylating agent in a solvent.
- the alkylating agent to be used may be a structural formula: S0 4 (wherein R represents the same meaning as described above).
- R represents the same meaning as described above.
- R represents a methyl group or an ethyl group.
- the amount of the alkylating agent to be added is 1 to 6 moles, preferably 2 to 4 moles, per mole of the mole of the product (21).
- the base examples include inorganic bases such as sodium hydroxide, sodium carbonate, sodium hydrogencarbonate, potassium hydroxide, potassium carbonate, potassium hydrogencarbonate, calcium hydroxide, calcium carbonate, barium hydroxide, and ammonia.
- An organic base an ion exchange resin having a pyridyl group or a dimethylaminobenzyl group, or the like.
- sodium hydroxide is particularly preferred.
- the amount of the base to be used is 1 to 10 moles, preferably 5 to 8 moles, per mole of the product (2b, ).
- the solvent which can be used is an inert solvent with respect to the product, and examples thereof include N-methyl-2-pyrrolidone, propylene carbonate, ethylene carbonate, butylene carbonate, dimethyl carbonate, and diethyl carbonate.
- ⁇ -butyrolactone 1,2-dimethoxyethane, tetrahydrofuran, 2-methyltetrahydrofuran, dimethyl sulfoxide, 1,3-dioxolane, formamide, dimethylformamide, dioxane Pentylene ring, acetonitrile, nitromethane, methyl formate, methyl acetate, triester phosphate, trimethoxyformamidine, dioxolane derivative, sulfolane, 3-methyl-2-oxazolone, propylene carbonate
- an aprotic organic solvent such as an ester derivative, a tetrahydrofuran derivative, diethyl ether, 1,3-propane sultone,
- the reaction conditions are as follows: The reaction temperature is 10 to 100 ° C, preferably 20 to 50 ° C, and the reaction time is 5 hours or longer, preferably 8 to 48 hours.
- step (2A) or (2B) after the completion of the reaction, purification is carried out as necessary to obtain a C 2 -symmetric, only chiral chiral bismuth double as shown by the structural formula (la) or (lb). Phosphine ligand.
- the amide ester (0.335 g, 0.36 mmd) was dissolved in tetrahydrofuran (20 mL), and then a sodium ethoxide solution obtained from sodium (0.6 g, 70 equiv.) and ethanol (40 mL) was added thereto at room temperature, and stirred at room temperature overnight. .
- the pH was adjusted to neutrality with a solution of 25% (v/v) acetic acid in methanol.
- the diol (14 mg, 0.022 mmol) was dissolved in DMF (5 mL) and sodium hydroxide (5 mg, 6 equiv.) and Me 2 S0 4 (8.4 L) were added and reacted between 20 and 50 ° C for 8 h.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/303,767 US8507705B2 (en) | 2006-06-08 | 2007-06-08 | C2-symmetrical ruthenocene diphosphine ligands only with surface chirality and their manufacture |
JP2009513539A JP5208928B2 (ja) | 2006-06-08 | 2007-06-08 | C2−対称の面性キラリティーだけをもつルテノセンビスホスフィン配位子及びその合成方法 |
CNA2007800211231A CN101466718A (zh) | 2006-06-08 | 2007-06-08 | C2-对称的只具有面手性的二茂钌双膦配体及其合成方法 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200610027409.8 | 2006-06-08 | ||
CN200610027408.3 | 2006-06-08 | ||
CNB2006100274098A CN100389118C (zh) | 2006-06-08 | 2006-06-08 | C2-对称的只具有面手性的二茂钌双膦配体 |
CNB2006100274083A CN100465181C (zh) | 2006-06-08 | 2006-06-08 | C2-对称的只具有面手性的二茂钌双膦配体的合成方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007140717A1 true WO2007140717A1 (fr) | 2007-12-13 |
Family
ID=38801067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2007/001824 WO2007140717A1 (fr) | 2006-06-08 | 2007-06-08 | Ligands diphosphine à motif ruthénocène de symétrie c2 n'ayant qu'une chiralité de surface et fabrication de ceux-ci |
Country Status (3)
Country | Link |
---|---|
US (1) | US8507705B2 (zh) |
JP (1) | JP5208928B2 (zh) |
WO (1) | WO2007140717A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102951981A (zh) * | 2011-08-22 | 2013-03-06 | 上海交通大学 | 一种酮类化合物的不对称氢化方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1166835A (zh) * | 1994-11-29 | 1997-12-03 | 隆萨股份公司 | 光学活性金属茂基膦的制备方法 |
JP2000256384A (ja) * | 1999-03-02 | 2000-09-19 | Fuji Chemical Industries Ltd | 新規な不斉配位子 |
WO2004099226A1 (en) * | 2003-05-09 | 2004-11-18 | Umicore Ag & Co. Kg | Substituted ferrocenyldiphosphines as ligands for homogeneous hydrogenation catalysts |
JP2005047883A (ja) * | 2003-07-31 | 2005-02-24 | Shinko Kagaku Kogyo Kk | ビス(エチルシクロペンタジエニル)ルテニウムの製造法 |
CN1876667A (zh) * | 2006-06-08 | 2006-12-13 | 上海交通大学 | C2-对称的只具有面手性的二茂钌双膦配体的合成方法 |
CN1876668A (zh) * | 2006-06-08 | 2006-12-13 | 上海交通大学 | C2-对称的只具有面手性的二茂钌双膦配体 |
CN1876666A (zh) * | 2006-06-08 | 2006-12-13 | 上海交通大学 | C2-对称手性二茂钌配体及其合成方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07223984A (ja) * | 1994-02-09 | 1995-08-22 | Kemipuro Kasei Kk | フェノール類の製造方法 |
JP2001039938A (ja) * | 1999-07-26 | 2001-02-13 | Tosoh Corp | シアノ化剤及びそれを用いたシアノ化合物の製造方法 |
JP2005139073A (ja) * | 2003-11-04 | 2005-06-02 | Sumitomo Chemical Co Ltd | 遷移金属錯体、配位子、オレフィン重合用触媒およびオレフィン重合体の製造方法 |
JP2010024171A (ja) * | 2008-07-17 | 2010-02-04 | Mitsubishi Chemicals Corp | カルボニル化合物の製造方法 |
-
2007
- 2007-06-08 US US12/303,767 patent/US8507705B2/en not_active Expired - Fee Related
- 2007-06-08 WO PCT/CN2007/001824 patent/WO2007140717A1/zh active Application Filing
- 2007-06-08 JP JP2009513539A patent/JP5208928B2/ja not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1166835A (zh) * | 1994-11-29 | 1997-12-03 | 隆萨股份公司 | 光学活性金属茂基膦的制备方法 |
JP2000256384A (ja) * | 1999-03-02 | 2000-09-19 | Fuji Chemical Industries Ltd | 新規な不斉配位子 |
WO2004099226A1 (en) * | 2003-05-09 | 2004-11-18 | Umicore Ag & Co. Kg | Substituted ferrocenyldiphosphines as ligands for homogeneous hydrogenation catalysts |
JP2005047883A (ja) * | 2003-07-31 | 2005-02-24 | Shinko Kagaku Kogyo Kk | ビス(エチルシクロペンタジエニル)ルテニウムの製造法 |
CN1876667A (zh) * | 2006-06-08 | 2006-12-13 | 上海交通大学 | C2-对称的只具有面手性的二茂钌双膦配体的合成方法 |
CN1876668A (zh) * | 2006-06-08 | 2006-12-13 | 上海交通大学 | C2-对称的只具有面手性的二茂钌双膦配体 |
CN1876666A (zh) * | 2006-06-08 | 2006-12-13 | 上海交通大学 | C2-对称手性二茂钌配体及其合成方法 |
Also Published As
Publication number | Publication date |
---|---|
US20110160474A1 (en) | 2011-06-30 |
JP5208928B2 (ja) | 2013-06-12 |
US8507705B2 (en) | 2013-08-13 |
JP2009539781A (ja) | 2009-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007125736A1 (ja) | メチレンジスルホネート化合物の製造方法 | |
KR20010030712A (ko) | 항엽산제 제조에 유용한 방법 및 중간체 | |
US7767825B2 (en) | 2,2′,6,6′-tetraoxazolinyl biphenyl ligand and method for preparing the same | |
CN107501112A (zh) | 一种手性β‑氨基酸的手性合成方法及医药中间体的合成方法 | |
JP2021536497A (ja) | アマンタジン系硝酸エステル誘導体の製造プロセス | |
US6262262B1 (en) | Processes and intermediates useful to make antifolates | |
CN113444057B (zh) | 单手性臂氨基酚磺酰胺配体及在不对称催化中的应用 | |
TWI397380B (zh) | 含磷之α胺基酸之製造方法及其製造中間體 | |
WO2007140717A1 (fr) | Ligands diphosphine à motif ruthénocène de symétrie c2 n'ayant qu'une chiralité de surface et fabrication de ceux-ci | |
CN101466718A (zh) | C2-对称的只具有面手性的二茂钌双膦配体及其合成方法 | |
JPH0378395B2 (zh) | ||
WO2014022975A1 (zh) | N-(4-(3-氨基-1h-吲唑-4-基)苯基)-n'-(2-氟-5-甲基苯基)脲及其中间体的制备方法 | |
CN103319480B (zh) | 一种制备2,3,4,9-四氢-β-咔啉-1-酮的方法 | |
CN108727323B (zh) | 一种氮杂环卡宾催化合成三氟甲基取代高异黄酮类化合物的方法 | |
WO2016115962A1 (zh) | 一种奈必洛尔中间体的制备方法及奈必洛尔的制备方法 | |
CN110423224B (zh) | 一种2-氨基嘧啶型抗血小板化合物的合成方法 | |
WO2012027951A1 (zh) | 一种合成培南类药物的中间体及其制备方法和应用 | |
US6090168A (en) | Processes and intermediates useful to make antifolates | |
CN114591226B (zh) | 一种烟醛衍生物的制备方法 | |
JP2014151285A (ja) | 新規光学活性イミダゾリン−リン酸触媒とその誘導体 | |
JPS585199B2 (ja) | 置換ペニシリン類の製造方法 | |
JP3986587B2 (ja) | ピラジンジカルボン酸誘導体及びその製造方法 | |
US7754891B2 (en) | 5,5′-Position linked 1,1′-biphenyl axial chiral ligand and method for preparing the same | |
KR101881918B1 (ko) | 아실설폰아마이드 유도체의 새로운 제조방법 | |
CN115785081A (zh) | 一种雷替曲塞的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780021123.1 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07721397 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009513539 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12303767 Country of ref document: US |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC ( THE EPO COMMUNICATIONS FORMS 1205A DATED: 16-02-2009 AND 18-06-2009) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07721397 Country of ref document: EP Kind code of ref document: A1 |